Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1/2 1Phase 1 1

Status

Terminated 3Withdrawn 2Unknown 1

Sponsor Class

OTHER 6NIH 2

Study Type

Interventional 6

Sponsor

Cancer Type

Genitourinary 6Thoracic 1Dermatologic 1Breast 1

Conditions

Prostatic Neoplasms 6Breast Neoplasms 3Pancreatic Neoplasms 2Neoplasms 2Neoplasm Metastasis 2Melanoma 2Kidney Neoplasms 2Carcinoma, Renal Cell 2Wilms Tumor 1Urinary Bladder Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Rectal Neoplasms 1Pain 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Neoplasms, Germ Cell and Embryonal 1Medulloblastoma 1Lymphoma, Non-Hodgkin 1Lymphoma 1Lung Neoplasms 1Hodgkin Disease 1Head and Neck Neoplasms 1Endometrial Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Brain Neoplasms 1

Interventions

Docetaxel 171Radiotherapy 144Magnetic Resonance Spectroscopy 142Leuprolide 112Prednisone 108enzalutamide 102Radiosurgery 101Abiraterone Acetate 94Androgen Antagonists 91Goserelin 83bicalutamide 81gallium 68 PSMA-11 70Surveys and Questionnaires 63apalutamide 57Specimen Handling 56acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 55Radiation 47Gonadotropin-Releasing Hormone 45Standard of Care 44Biopsy 44Brachytherapy 42Radiotherapy, Intensity-Modulated 40Blood Specimen Collection 40darolutamide 39abiraterone 39cabazitaxel 35Exercise 35Carboplatin 33Pluvicto 32Triptorelin Pamoate 31

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
OTHER × Prostatic Neoplasms × Genistein × Clear all
NCT02766478 2022-09-27

GeniPro

Emory University

Phase 2 Terminated
10 enrolled 10 charts
Genitourinary

Prostatic Neoplasms

NCT01126879 2019-09-10

Genistein in Treating Patients With Prostate Cancer

Northwestern University

Phase 2 Terminated
12 enrolled 8 charts
Genitourinary

Prostatic Neoplasms

NCT00769990 2017-12-13

Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases

Masonic Cancer Center, University of Minnesota

Phase 1/2 Withdrawn
BreastDermatologicGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Kidney Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Pain, Prostatic Neoplasms, Small Cell Lung Carcinoma

NCT00058266 2012-07-19

Genistein in Treating Patients With Localized Prostate Cancer Who Are Planning to Undergo Radical Prostatectomy

Northwestern University

Phase 2 Terminated
36 enrolled
Genitourinary

Prostatic Neoplasms

NCT00005827 2012-04-24

Genistein in Treating Patients With Stage II, Stage III, or Stage IV Prostate Cancer

UNC Lineberger Comprehensive Cancer Center

Phase 1 Withdrawn
Genitourinary

Prostatic Neoplasms

NCT00546039 2008-09-30

Synthetic Genistein (BONISTEINâ„¢) in Patients Who Are Undergoing Surgery for Prostate Cancer

University Hospital, Aker

Phase 2 Unknown
47 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡